- Home
- NB vs CCEL Comparison
NB vs CCEL Comparison
Compare NB & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NB
- CCEL
- Stock Information
- Founded
- NB 1987
- CCEL 1989
- Country
- NB United States
- CCEL United States
- Employees
- NB N/A
- CCEL N/A
- Industry
- NB Metal Mining
- CCEL Managed Health Care
- Sector
- NB Basic Materials
- CCEL Health Care
- Exchange
- NB Nasdaq
- CCEL Nasdaq
- Market Cap
- NB 56.9M
- CCEL 50.0M
- IPO Year
- NB N/A
- CCEL 1997
- Fundamental
- Price
- NB $1.41
- CCEL $7.78
- Analyst Decision
- NB Strong Buy
- CCEL
- Analyst Count
- NB 1
- CCEL 0
- Target Price
- NB $8.50
- CCEL N/A
- AVG Volume (30 Days)
- NB 183.0K
- CCEL 13.9K
- Earning Date
- NB 02-11-2025
- CCEL 12-24-2024
- Dividend Yield
- NB N/A
- CCEL 3.14%
- EPS Growth
- NB N/A
- CCEL N/A
- EPS
- NB N/A
- CCEL N/A
- Revenue
- NB N/A
- CCEL $31,838,476.00
- Revenue This Year
- NB N/A
- CCEL $3.97
- Revenue Next Year
- NB N/A
- CCEL $0.91
- P/E Ratio
- NB N/A
- CCEL N/A
- Revenue Growth
- NB N/A
- CCEL 1.95
- 52 Week Low
- NB $1.27
- CCEL $4.47
- 52 Week High
- NB $4.00
- CCEL $9.50
- Technical
- Relative Strength Index (RSI)
- NB 47.42
- CCEL 45.13
- Support Level
- NB $1.36
- CCEL $7.60
- Resistance Level
- NB $1.74
- CCEL $9.10
- Average True Range (ATR)
- NB 0.12
- CCEL 0.27
- MACD
- NB 0.01
- CCEL -0.15
- Stochastic Oscillator
- NB 30.95
- CCEL 23.61
About NB NioCorp Developments Ltd.
NioCorp Developments Ltd is engaged in exploration and development of mineral deposits in North America, specifically, the Elk Creek Niobium/Scandium/Titanium property.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from cellular processing and cryogenic storage and it derives revenue from processing and testing fees and storage segment.